Effecty scores 87/100 (grade B+, ranked #14) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
Carries one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide plus needle-free oral and microdosed routes, PT-141, intranasal NAD+ and a wall of recovery peptides — and backs it with a checkable LegitScript certification and HIPAA compliance, but the verdict docks it hard because every line is compounded, not FDA-approved, and the pricing turns opaque the moment you look past the headline GLP-1 tiers.
Telos Rx scores 85/100 to Effecty's 87; our full write-up on Telos Rx has the pricing conditions and the caveats in detail.
Earns its keep on pricing transparency — every tier is published, dose-flat and includes combo and microdose options — but the verdict holds it back for a compounded-only formulary and a state map it won't show.
Enhance MD scores 85/100 to Effecty's 87; our full write-up on Enhance MD has the pricing conditions and the caveats in detail.
One of the rare compounded programs that puts its price on the page — $199 semaglutide and $299 tirzepatide, both molecules, nationwide — wrapped in a broader longevity menu, but the verdict holds it at mid-pack because everything is compounded, injectable-only, and the 50-state and results claims are self-reported with a thin independent track record.
yourEra scores 84/100 to Effecty's 87; our full write-up on yourEra has the pricing conditions and the caveats in detail.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.